Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering.
Residues important in the interaction between the 23-residue transmembrane (TM) domains of the integrin alpha(IIb)- and beta(3)-subunits were identified by mutating each non-Leu residue to Leu. Leu substitutions of alpha(IIb) at G972, G976, and T981, and of beta(3) at I693 and G708, increased ligand binding. Substitutions with other amino acids at alpha(IIb)G972 and beta(3)G708 could also increase ligand binding. The results are consistent with and extend the helical interface between the integrin alpha- and beta-subunit TM domains previously defined by cysteine scanning and disulfide bond formation. We differentiated between affinity- and valency-based modes of activation by TM domain mutations. The mutant alpha(IIb) W967C forms disulfide-linked alpha(IIb)-subunits within an (alpha(IIb)beta(3))(2) tetramer. This tetramer behaved as an ideal model for the valency mode of regulation, because it exhibited significantly increased binding to multivalent but not monovalent ligands and basally retained the bent conformation. By contrast, the activating Leu mutants showed increased binding to the monovalent, ligand-mimetic PAC-1 Fab and increased exposure of ligand-induced binding site (LIBS) epitopes, suggesting that they partially adopt an extended conformation. Furthermore, the previously described beta(3)G708N mutation in Chinese hamster ovary cells enhanced ligand binding affinity, not valency, and did not alter cell-surface clustering as defined by confocal microscopy. Our studies provide evidence that disrupting the integrin heterodimeric TM helix-helix interface activates ligand binding mainly by increasing the monomeric affinity for ligand, but not the receptor valency, i.e., clustering.
Luo
Bing-Hao
BH
The CBR Institute for Biomedical Research and Department of Pathology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA.
Carman
Christopher V
CV
Takagi
Junichi
J
Springer
Timothy A
TA
D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D016466:CHO Cells; D002462:Cell Membrane / Q000737:chemistry; D006224:Cricetinae; D019281:Dimerization; D004220:Disulfides / Q000737:chemistry; D008024:Ligands; D008969:Molecular Sequence Data; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000737:chemistry*; D017433:Protein Structure, Secondary
D004220:Disulfides; D008024:Ligands; D019039:Platelet Glycoprotein GPIIb-IIIa Complex
Cell. 2002 Sep 6;110(5):599-11
12230977
Biochemistry. 1992 Dec 29;31(51):12719-25
1463743
J Biol Chem. 1999 Sep 17;274(38):26869-77
10480895
J Biol Chem. 2004 Jun 25;279(26):27466-71
15123676
J Cell Biol. 2001 Dec 24;155(7):1319-32
11756480
Scanning Microsc. 1987 Jun;1(2):745-56
3616571
J Cell Biol. 2002 Sep 2;158(5):833-9
12213832
Curr Opin Cell Biol. 2003 Oct;15(5):547-56
14519389
J Cell Biol. 1984 Sep;99(3):822-9
6088559
Cell. 2004 Feb 6;116(3):431-43
15016377
Am Heart J. 1998 May;135(5 Pt 2 Su):S179-83
9588397
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12462-7
11606749
Mol Cell Biol. 1987 Jan;7(1):379-87
3031469
Science. 2003 Sep 19;301(5640):1720-5
14500982
J Biol Chem. 2004 Jun 18;279(25):26666-73
15067009
Trends Biochem Sci. 1998 Jan;23(1):30-4
9478133
J Cell Biol. 2001 Jun 25;153(7):1427-40
11425873
Immunity. 2000 Dec;13(6):759-69
11163192
J Cell Biol. 2004 Dec 20;167(6):1241-53
15611342
J Biol Chem. 1994 Jul 22;269(29):18781-8
7518445
Biochem J. 2001 Jul 15;357(Pt 2):529-36
11439104
Nature. 2004 Nov 4;432(7013):59-67
15378069
Cell. 2002 Sep 20;110(6):673-87
12297042
Thromb Haemost. 1996 Dec;76(6):1038-46
8972029
Cell. 2002 Sep 6;110(5):587-97
12230976
Proc Natl Acad Sci U S A. 1987 Oct;84(20):7114-8
2444974
J Biol Chem. 1996 Mar 22;271(12):6571-4
8636068
J Biol Chem. 2003 Apr 25;278(17):15217-24
12595537
Science. 2003 May 2;300(5620):795-8
12730600
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2403-8
12604783
J Clin Invest. 1996 May 1;97(9):2139-44
8621804
J Biol Chem. 1993 Nov 5;268(31):23087-92
7693683
Immunol Rev. 2002 Aug;186:141-63
12234369
PLoS Biol. 2004 Jun;2(6):e153
15208712
Immunol Rev. 2002 Aug;186:164-71
12234370
J Cell Biol. 1987 Jun;104(6):1655-63
3584243